TrialScientific reports2022

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response.

Henry H L Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.